IL126698A0 - Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression - Google Patents
Use of phosphonic acid esters for the treatment of functional disorders of the brain and depressionInfo
- Publication number
- IL126698A0 IL126698A0 IL12669897A IL12669897A IL126698A0 IL 126698 A0 IL126698 A0 IL 126698A0 IL 12669897 A IL12669897 A IL 12669897A IL 12669897 A IL12669897 A IL 12669897A IL 126698 A0 IL126698 A0 IL 126698A0
- Authority
- IL
- Israel
- Prior art keywords
- brain
- depression
- treatment
- acid esters
- phosphonic acid
- Prior art date
Links
- 210000004556 brain Anatomy 0.000 title 1
- 150000003008 phosphonic acid esters Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19616471A DE19616471A1 (de) | 1996-04-25 | 1996-04-25 | Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen |
| PCT/US1997/006469 WO1997039756A1 (en) | 1996-04-25 | 1997-04-17 | Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL126698A0 true IL126698A0 (en) | 1999-08-17 |
Family
ID=7792381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12669897A IL126698A0 (en) | 1996-04-25 | 1997-04-17 | Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0896540A1 (id) |
| JP (1) | JP2000510455A (id) |
| KR (1) | KR20000010611A (id) |
| AR (1) | AR006870A1 (id) |
| AU (1) | AU2462397A (id) |
| BG (1) | BG102864A (id) |
| BR (1) | BR9709300A (id) |
| CA (1) | CA2252567A1 (id) |
| CZ (1) | CZ343498A3 (id) |
| DE (1) | DE19616471A1 (id) |
| HU (1) | HUP9903366A3 (id) |
| ID (1) | ID16678A (id) |
| IL (1) | IL126698A0 (id) |
| NO (1) | NO984964L (id) |
| PL (1) | PL333464A1 (id) |
| SK (1) | SK146398A3 (id) |
| TR (1) | TR199802137T2 (id) |
| WO (1) | WO1997039756A1 (id) |
| ZA (1) | ZA973538B (id) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1078370B (de) * | 1958-09-16 | 1960-03-24 | Norddeutsche Affinerie | Schaedlingsbekaempfungsmittel |
| US3069312A (en) * | 1960-09-28 | 1962-12-18 | California Research Corp | N-substituted dimethyl 1-carbamoyloxy-2, 2, 2-trichloroethyl phosphonates as insecticidal compositions |
| NL292791A (id) * | 1962-05-16 | 1900-01-01 | ||
| DE1193044B (de) * | 1963-08-05 | 1965-05-20 | Bayer Ag | Verfahren zur Herstellung phosphorylierter Urethane |
| DE2512375A1 (de) * | 1975-03-21 | 1976-09-30 | Bayer Ag | 1-hydroxy-2,2,2-trichloraethan- thionophosphonsaeuredialkylester, verfahren zu ihrer herstellung sowie ihre verwendung als insektizide |
| US4950658A (en) * | 1988-12-06 | 1990-08-21 | Board Of Trustees Of Southern Illinois Univ. | Method of medical treatment of Alzheimer's disease |
-
1996
- 1996-04-25 DE DE19616471A patent/DE19616471A1/de not_active Withdrawn
-
1997
- 1997-04-17 CZ CZ983434A patent/CZ343498A3/cs unknown
- 1997-04-17 HU HU9903366A patent/HUP9903366A3/hu unknown
- 1997-04-17 PL PL97333464A patent/PL333464A1/xx unknown
- 1997-04-17 SK SK1463-98A patent/SK146398A3/sk unknown
- 1997-04-17 JP JP09538197A patent/JP2000510455A/ja active Pending
- 1997-04-17 KR KR1019980708502A patent/KR20000010611A/ko not_active Application Discontinuation
- 1997-04-17 BR BR9709300A patent/BR9709300A/pt not_active Application Discontinuation
- 1997-04-17 TR TR1998/02137T patent/TR199802137T2/xx unknown
- 1997-04-17 WO PCT/US1997/006469 patent/WO1997039756A1/en not_active Application Discontinuation
- 1997-04-17 AU AU24623/97A patent/AU2462397A/en not_active Abandoned
- 1997-04-17 CA CA002252567A patent/CA2252567A1/en not_active Abandoned
- 1997-04-17 IL IL12669897A patent/IL126698A0/xx unknown
- 1997-04-17 EP EP97920431A patent/EP0896540A1/en not_active Withdrawn
- 1997-04-24 ZA ZA9703538A patent/ZA973538B/xx unknown
- 1997-04-24 ID IDP971362A patent/ID16678A/id unknown
- 1997-04-25 AR ARP970101724A patent/AR006870A1/es unknown
-
1998
- 1998-10-22 BG BG102864A patent/BG102864A/xx unknown
- 1998-10-23 NO NO984964A patent/NO984964L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID16678A (id) | 1997-10-30 |
| SK146398A3 (en) | 1999-06-11 |
| CZ343498A3 (cs) | 1999-02-17 |
| PL333464A1 (en) | 1999-12-20 |
| AR006870A1 (es) | 1999-09-29 |
| BG102864A (en) | 1999-09-30 |
| HUP9903366A3 (en) | 2000-08-28 |
| WO1997039756A1 (en) | 1997-10-30 |
| HUP9903366A2 (en) | 2000-07-28 |
| TR199802137T2 (xx) | 1999-02-22 |
| DE19616471A1 (de) | 1997-10-30 |
| NO984964D0 (no) | 1998-10-23 |
| BR9709300A (pt) | 1999-08-10 |
| EP0896540A1 (en) | 1999-02-17 |
| AU2462397A (en) | 1997-11-12 |
| ZA973538B (en) | 1997-11-18 |
| CA2252567A1 (en) | 1997-10-30 |
| NO984964L (no) | 1998-12-22 |
| JP2000510455A (ja) | 2000-08-15 |
| KR20000010611A (ko) | 2000-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9800033A3 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| IL133800A0 (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
| GB2305605B (en) | Pipecolic acid derivatives for the treatment of neurological disorders | |
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| AU6396598A (en) | Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders | |
| IL123637A (en) | Steroid esters useful against skin disorders | |
| PL339425A1 (en) | Treatment of behavioural disorders | |
| AU5981098A (en) | Therapeutic gestagens for the treatment of premenstrual dysphoric disorder | |
| IL127146A0 (en) | Transdermal propentofylline compositions for the treatment of alzheimer's disease | |
| AU2058697A (en) | Treatment of sleep disorders | |
| IL118289A0 (en) | The use of glyceryl triacetate for treatment of onychomycoses | |
| IL129144A0 (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases | |
| AU1578295A (en) | Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders | |
| PL332313A1 (en) | Application of benzopyranoles in treatment of neurological disorders | |
| AU1831195A (en) | Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders | |
| HUP0000785A3 (en) | Ointment for the treatment of burns and other skin diseases | |
| IL131347A0 (en) | Treatment of skin disorders | |
| IL126698A0 (en) | Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression | |
| AU5446798A (en) | Compositions and methods for the treatment of gastrointestinal disorders | |
| AU9162298A (en) | Use of cyclic phosphonic acid esters for the treatment of impaired cerebral function and depression | |
| ZA985818B (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. | |
| AU9260198A (en) | Use of cycloalcane-phosphonic acid esters for treating mental disorders and depressions | |
| AU4486797A (en) | Compositions and methods useful for the treatment of neurological and mental disorders | |
| IL106917A0 (en) | Compositions for the treatment of skin disorders | |
| GB9619125D0 (en) | Treatment of functional disorders of the pilosebaceous system |